Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Akari Therapeutics (AKTX)

6.5105 +0.0305 (+0.4707%)

10/17/2017  2:43pm

Open:

6.4000

Pre. Close:

6.4800

High:

6.7356

Low:

6.3200

Volume:

35,760

Market Cap:

76.67M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.83 - 6.99

6.99 - 7.28

Low:

5.92 - 6.09

6.09 - 6.41

Close:

6.25 - 6.44

6.44 - 6.79

Technical analysis  (as of: 2017-10-17 2:30:59 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 10.92     One year: 13.96

Support:

Support1: 5.15    Support2: 4.28

Resistance:

Resistance1: 9.35    Resistance2: 11.95

Pivot:

6.33

Moving Averages:

MA(5): 6.73     MA(20): 6.59

MA(100): 5.04     MA(250): 7.31

MACD:

MACD(12,26): 0.32     Signal(12,26,9): 0.38

%K %D:

%K(14,3): 26.00     %D(3): 25.95

RSI:

RSI(14): 53.74

52-Week:

High: 22.1998  Low: 3.1832  Change(%): -28.8

Average Vol(K):

3-Month: 39064  10-Days 32897

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AKTX has closed below upper band by 42.2%. Bollinger Bands are 22.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 22 Sep 2015 05:22:55 GMT
6.48

Thu, 17 Sep 2015 13:31:07 GMT
Akari Therapeutics PLC ADR

Fri, 31 Mar 2017 12:00:00 GMT
3 Stocks to Watch on Friday: BlackBerry Ltd (BBRY), Akari Therapeutics PLC ...

Fri, 22 Sep 2017 17:37:30 GMT
Akari Therapeutics Rally Continues As William Blair Upgrades

Thu, 12 Oct 2017 14:03:45 GMT
Akari Therapeutics PLC (ADR) (NASDAQ:AKTX) Skyrockets 22%

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

11.00

Shares Float (M)

3.71

% Held by Insiders

0.51

% Held by Institutions

26.57

Shares Short (K)

85

Shares Short Prior Month (K)

53

Stock Financials

EPS

-2.000

EPS Est. Current Year

-2.360

EPS Est. Next Year

-3.110

EPS Est. Next Quarter

-0.690

Forward EPS

-1.411

Book Value (p.s.)

1.940

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-43.9

Return on Equity (ttm)

-68.1

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.860

Qtrly Earnings Growth

Operating Cash Flow (M)

-25.36

Levered Free Cash Flow (M)

-23.58

FoxReading.com

Valuation

P/E

-3.23

P/E Growth Ratio

P/BV

3.34

P/S

P/CF

-2.81

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2015-09-17

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.